Europe PMCopen access
Molecular targeted therapy in combination with chemotherapy for the treatment of platinum-resistant/refractory ovarian cancer (PROC): a systematic review and network meta-analysis
Bevacizumab, Sorafenib, Molecular Targeted Drugs, Bayesian Network Meta-analysis, Platinum-resistant/refractory Ovarian Cancer (Proc)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 4614
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.